These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3748849)

  • 1. Helodermin has a VIP-like effect upon canine blood flow.
    Naruse S; Yasui A; Kishida S; Kadowaki M; Hoshino M; Ozaki T; Robberecht P; Christophe J; Yanaihara C; Yanaihara N
    Peptides; 1986; 7 Suppl 1():237-40. PubMed ID: 3748849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of helodermin, VIP and PHI in pancreatic secretion and blood flow in dogs.
    Konturek SJ; Yanaihara N; Pawlik W; Jaworek J; Szewczyk K
    Regul Pept; 1989 Feb; 24(2):155-66. PubMed ID: 2922493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular effects of helodermin, helospectin I and helospectin II: a comparison with vasoactive intestinal peptide (VIP).
    Grundemar L; Högestätt ED
    Br J Pharmacol; 1990 Mar; 99(3):526-8. PubMed ID: 2331581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of vasoactive intestinal peptide, helodermin and galanin on responses of guinea-pig lung parenchyma to histamine, acetylcholine and leukotriene D4.
    Conroy DM; Samhoun MN; Piper PJ
    Br J Pharmacol; 1991 Dec; 104(4):1012-8. PubMed ID: 1725762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic response of the pancreas to synthetic chicken VIP in dogs.
    Inoue K; Suzuki T; Tobe T; Yajima H
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():65-9. PubMed ID: 7227321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.
    Zhou ZC; Gardner JD; Jensen RT
    Am J Physiol; 1989 Feb; 256(2 Pt 1):G283-90. PubMed ID: 2465694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helodermin, but not cholecystokinin, somatostatin, or thyrotropin releasing hormone, acutely increases thyroid blood flow in the rat.
    Huffman L; Michalkiewicz M; Pietrzyk Z; Hedge GA
    Regul Pept; 1990 Nov; 31(2):101-14. PubMed ID: 1980023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new type of functional VIP receptor has an affinity for helodermin in human SUP-T1 lymphoblasts.
    Robberecht P; Waelbroeck M; De Neef P; Tastenoy M; Gourlet P; Cogniaux J; Christophe J
    FEBS Lett; 1988 Feb; 228(2):351-5. PubMed ID: 2830146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of VIP and helodermin on thyroid hormone secretion in the mouse.
    Ahrén B; Hedner P
    Neuropeptides; 1989 Jan; 13(1):59-64. PubMed ID: 2922106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the vasodilatory effects of vasoactive intestinal polypeptide (VIP) and peptide-HI (PHI) in the rabbit and the cat.
    Nilsson SF; Mäepea O
    Acta Physiol Scand; 1987 Jan; 129(1):17-26. PubMed ID: 3565040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helodermin stimulates prolactin secretion in the rat.
    Koshiyama H; Kato Y; Inoue T; Christophe J; Yanaihara N; Imura H
    Eur J Pharmacol; 1987 Sep; 141(2):319-21. PubMed ID: 3678365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular effects of the peptides PYY and PHI: comparison with APP and VIP.
    Lundberg JM; Tatemoto K
    Eur J Pharmacol; 1982 Sep; 83(1-2):143-6. PubMed ID: 6897040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of helodermin and VIP on insulin and glucagon secretion in the mouse.
    Ahrén B; Falck B
    Regul Pept; 1991 Jan; 32(1):1-9. PubMed ID: 2003148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasodilator effect of pituitary adenylate cyclase activating polypeptide (PACAP) on femoral blood flow in dogs.
    Naruse S; Suzuki T; Ozaki T; Nokihara K
    Peptides; 1993; 14(3):505-10. PubMed ID: 8101368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intestinal polypeptide (VIP): effects in the eye and on regional blood flows.
    Nilsson SF; Bill A
    Acta Physiol Scand; 1984 Aug; 121(4):385-92. PubMed ID: 6148840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasodilator action of guinea pig vasoactive intestinal polypeptide (VIP): comparison with common mammalian VIP.
    Naruse S; Inoue T; Mochizuki T; Yanaihara N
    Regul Pept; 1992 Dec; 42(3):163-71. PubMed ID: 1289976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional haemodynamic responses to pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide in conscious rats.
    Gardiner SM; Rakhit T; Kemp PA; March JE; Bennett T
    Br J Pharmacol; 1994 Feb; 111(2):589-97. PubMed ID: 7911721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glibenclamide-sensitive hypotension produced by helodermin assessed in the rat.
    Horikawa N; Kataha K; Watanabe N; Ishii K; Yanaihara N; Tanaka Y; Shigenobu K; Nakayama K
    Biol Pharm Bull; 1998 Dec; 21(12):1290-3. PubMed ID: 9881641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional vascular influences of vasoactive intestinal polypeptide.
    Blitz W; Charbon GA
    Scand J Gastroenterol; 1983 Sep; 18(6):755-63. PubMed ID: 6669940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic and pancreatic actions of purified porcine and synthetic vasoactive intestinal peptide (VIP).
    Blitz W; Beijer HJ; Charbon GA
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):66-76. PubMed ID: 4062433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.